Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Fibrocystic changes are the most frequently occurring benign conditions of breast disease. Women of 20 to 50 years of age who frequently encounter various forms of stressors have the highest incidence of fibrocystic breast disease (FBD). In cases, where any palpable mass is detected after clinical examination, mammograms and ultrasonography (USG) are the most common investigative tools for the next level of assessment. Five patients with FBD were treated with homoeopathic medicines in our hospital within a period of 3 years under the project: ‘Homoeopathic management of benign neoplastic lesions of breast: an evidence-based study’. The diagnosis was based on clinical examination and USG. We followed standard homoeopathic guidelines for the final selection of medicines. Individualised homoeopathic medicines were used to treat these cases. The clinical assessment was done every month and objective assessment was done after serial USG reports at every 6-month interval. All the patients had notable improvements during treatment as inferred clinically as well as from the USG reports. Few associated symptoms improved too. Assessment of the causal attribution of the outcomes of the treated cases to the homoeopathic intervention was done using Modified Naranjo Criteria. ‘Definite’ association was found in four out of five cases and one case showed a ‘probable’ association. Therefore, we may conclude that homoeopathic treatment can be useful in treating FBD. Good-quality clinical trials are needed before making any firm recommendation.
Fibrocystic changes are the most frequently occurring benign conditions of breast disease. Women of 20 to 50 years of age who frequently encounter various forms of stressors have the highest incidence of fibrocystic breast disease (FBD). In cases, where any palpable mass is detected after clinical examination, mammograms and ultrasonography (USG) are the most common investigative tools for the next level of assessment. Five patients with FBD were treated with homoeopathic medicines in our hospital within a period of 3 years under the project: ‘Homoeopathic management of benign neoplastic lesions of breast: an evidence-based study’. The diagnosis was based on clinical examination and USG. We followed standard homoeopathic guidelines for the final selection of medicines. Individualised homoeopathic medicines were used to treat these cases. The clinical assessment was done every month and objective assessment was done after serial USG reports at every 6-month interval. All the patients had notable improvements during treatment as inferred clinically as well as from the USG reports. Few associated symptoms improved too. Assessment of the causal attribution of the outcomes of the treated cases to the homoeopathic intervention was done using Modified Naranjo Criteria. ‘Definite’ association was found in four out of five cases and one case showed a ‘probable’ association. Therefore, we may conclude that homoeopathic treatment can be useful in treating FBD. Good-quality clinical trials are needed before making any firm recommendation.
Purpose: Breast cancer patients often experience high levels of psychological distress, but there is limited research on the psychological distress status of patients with benign breast diseases. This study aims to investigate the psychological distress levels and influencing factors among patients with benign breast disease (BBD). Methods: A cross-sectional study was conducted on BBD patients admitted to a tertiary medical center in China between November 2022 and May 2023. Patient-reported distress and problems were assessed using the distress thermometer (DT) and the 42-item Problem List by the National Comprehensive Cancer Network. Descriptive statistics, chi-square test or Fisher's exact test, and multivariate logistic regression analyses were performed. Receiver operating characteristic analysis was used to evaluate the diagnostic accuracy of the DT in comparison to the Hospital Anxiety and Depression Scale (HADS) and to determine an optimal cutoff score for the DT in this specific population. Results: Among the 255 BBD patients, the mean psychological distress score was 3.69±1.96. The prevalence of psychological distress (≥4 points) was 52%. The main factors causing psychological distress were worry or anxiety (43.5%), fear (21.2%), pain (7.1%), sleep problems (6.7%), and child care responsibilities (5.1%). Multiple logistic regression analysis revealed that age, education, employment, and BI-RADS classification were factors associated with psychological distress in BBD patients. ROC curve analyses showed that a DT cutoff score of 4 had an area under the ROC curve of 0.88 and 0.7 when compared to HADS-A and HADS-D, respectively, indicating good overall accuracy. Conclusions: Patients with benign breast disease also experience significant psychological burden, which requires attention from healthcare professionals. Targeted health education and psychological counseling should be provided to these patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.